Tweet
<img alt="" height="1" width="1" />
Orexigen Data Grabs Investor Attention In Beaten-Down Stock
Wall Street Journal
NEW YORK (Dow Jones)--Orexigen Therapeutics Inc. (OREX) presented data on its lead experimental weight-loss drug that grabbed the attention of investors, sending the stock up as much as 16%, coming off its lowest ...
Orexigen says obesity drug treated depressionBusinessWeek
Orexigen, Amylin gain on diabetes studiesMarketWatch
Upside Purchased on Orexigen Therapeutics (OREX)Benzinga
Motley Fool -North County Times (blog) -News-Medical.net
all 19 news articles »
More...